1. Introduction
===============

Bacterial liver abscess ranked second in hepatic infectious disease and can be life-threatening. It is caused by various organisms, including *Escherichia coli*, *Klebsiella pneumoniae*, *Streptococcus anginosus*, and anaerobes such as *Bacteroides*.^\[[@R1]--[@R3]\]^ Bacterial liver abscess is commonly seen in patients with liver diseases, biliary diseases, diabetes, and in patients who have undergone invasive operations.^\[[@R4]\]^ Previous population-based study of pyogenic liver abscess in North America reported that the most commonly recorded bacterial infections were caused by *Streptococcus* species (29.5%) and *E coli* (18.1%).^\[[@R5]\]^ However, in recent years, the incidence of bacterial liver abscess has continuously increased from 1.1/100,000 to 17.6/100,000 individuals, especially liver abscess caused by *K pneumoniae*.^\[[@R5]--[@R8]\]^ In the United States, the incidence of bacterial liver abscess increased from 2.7 per 100,000 individuals in 1994 to 4.1 per 100,000 individuals in 2005, with an annual increase of 4.1%.^\[[@R5]\]^ In Taiwan, the incidence was higher than that in the United States, and also increased from 10.83 per 100,000 individuals in 2000 to 15.45 per 100,000 individuals in 2011.^\[[@R6]\]^ In Denmark, between 1977 and 2002, the incidence increased from 0.6 to 1.8 per 100,000 individuals.^\[[@R7]\]^ In China, the annual incidence of bacterial liver abscess and liver abscess caused by *K pneumoniae* increased from 0.266% and 0.155% during the 10-year period of 1994 to 2003, to 0.448% and 0.290% in the next 11 years from 2004 to 2015, respectively.^\[[@R8]\]^ Community-acquired pyogenic liver abscess caused by *K pneumoniae* has emerged in Taiwan and other Asian countries, although it was rarely reported in China.^\[[@R9]\]^ Therefore, clinical manifestations of patients with pyogenic liver abscess and pathogenic characteristics of their infections were analyzed in this study, in order to provide suggestions for early and accurate diagnose of bacterial liver abscess, and to find the effective therapeutic methods, especially the use of the appropriate antibiotics. In this study, we analyzed the clinical and etiological characteristics of patients with bacterial liver abscess treated in our hospital from January 2013 to December 2015. We aimed to explore the clinical and pathogenic features of bacterial liver abscess more deeply and provide basic information for the prevention and treatment.

2. Methods
==========

2.1. Patients
-------------

This retrospective study was conducted with the approval from the Ethics Committee of Nanjing First Hospital, Nanjing Medical University. Written informed consent was obtained from all participants.

A total of 178 patients with fever, chills, abdominal pain, as well as other clinical manifestations, were diagnosed with liver abscess lesions by abdominal ultrasound or CT, and positive puncture fluid culture.

The patients were treated by ultrasound or CT-guided percutaneous portal vein catheterization and drainage combined with intravenous infusion of antibiotics (the third-generation cephalosporins, the coformulation of carbapenem and dehydropeptidase-I inhibitors, or the coformulation of tazobactam and piperacillin). The course of treatment ranged within 2 to 4 weeks.

2.2. Analysis of the clinical data of the patients
--------------------------------------------------

Medical records of the 178 patients were acquired from the medical record inquiry system. Clinical data, laboratory data, and imaging data obtained from the medical records of these patients were summarized and analyzed.

The outcomes of the patients were categorized into 2 groups, that is, "Cure and improvement," which meant favorable outcomes, and "Death, infectious shock or the accompanying liver cancer," which meant that the patients had poor outcomes.

2.3. Analysis of the bacteria and their drug sensitivity
--------------------------------------------------------

A total of 102 etiological samples isolated from the pyogenic liver abscesses of the patients were retrospectively analyzed, and drug sensitivity rates of the pathogens were also calculated.

The pus culture and drug sensitivity test were routine laboratory work to identify the pathogens that caused the liver abscess. Pus was directly inoculated on blood agar and China blue plate culture, and bacteria were identified using the VITEK II microbial identification system (bioMérieux, Rhône-Alpes, France).

The drug sensitivity of the bacteria was determined by analyzing the minimum inhibitory concentration using the drug sensitive card (bioMérieux). The selection of antibiotics and the interpretation of the drug sensitivity results was based on American Clinical and Laboratory Standards Institute recommendations.^\[[@R10],[@R11]\]^ These results were analyzed using Whonet 5.6.

2.4. Statistical analysis
-------------------------

Statistical analysis was performed using the SPSS (version 22.0) statistical software package. The *χ*^2^ test was used to evaluate the differences in the categorical variables. The Student *t* test was used to evaluate the differences in the continuous variables. *P* \< .05 was considered statistically significant in all analyses.

3. Results
==========

3.1. Clinical features of the patients
--------------------------------------

In this retrospective study, among the 178 cases, 112 cases were male, 66 cases were female. The age of these patients ranged from 22 to 84 years (average age: 52.1 ± 15.4 years), and the ages of most patients were within 40 to 70 years (164/178, 92.1%). Furthermore, the samples of 102 patients were positive for bacteria in the pus culture.

The most common clinical and hematological features were fever (163/178, 91.2%), single abscess (146/178, 82.0%), elevated white blood cell (WBC) count and increased percentage of neutrophils (136/178, 76.4%). Among these patients, a total of 145 patients (81.5%) had diabetes mellitus. The proportion of patients with diabetes mellitus differed significantly from the patients without diabetes mellitus (Chi-square value 24.472, *P* \< .05).

Five cases had aggravated conditions, including death, infectious shock and the accompanying liver cancer, while others were getting better or were discharged from the hospital (Table [1](#T1){ref-type="table"}). Migratory pulmonary lesions were found in 1 patient.
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Demographic characteristics and clinical features of 102 patients with PLA.
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3.2. Outcomes of the patients
-----------------------------

Among the 178 patients, 5 patients had poor outcomes due to infectious shock or the accompanying liver cancer (the "Death, infectious shock or accompanying liver cancer" group). After appropriate antimicrobial treatment (the third-generation cephalosporins, the coformulation of carbapenem and dehydropeptidase-I inhibitors, or the coformulation of tazobactam and piperacillin), assisted by puncture drainage or surgical treatment guided by ultrasound, the body temperature of the 173 patients (the "Cure and improvement" group) returned to normal levels. Ultrasonic reexamination revealed that the area of abscess decreased, and the inflammatory indices, such as the total white blood cells count and C-reactive protein, returned to normal levels, and the outcome was thus good.

3.3. Analysis of the pathogens and results
------------------------------------------

A total of 102 nonrepetitive strains were isolated from 178 cases, including 82 strains of *K pneumoniae* (80.3%), 8 strains of *E coli*, 2 strains of *Pseudomonas aeruginosa*, one strain of *Acinetobacter baumannii*, and 9 strains of Gram-positive *cocci*. Susceptibility of these bacteria to antibiotics was determined by analyzing the minimal inhibitory concentration of the antibiotics, and the results revealed that 5 strains of *E coli* produced extended-spectrum β-lactamases (ESBLs), which were among the most commonly seen nosocomial infections. These results indicate that the most common organism identified from the liver abscess aspiration cultures was *K pneumoniae*. The drug resistance of the 82 strains of *K pneumoniae* is shown in Table [2](#T2){ref-type="table"}. In addition, in 78 patients (95.1%), the empirical use of antibiotics matched with the sensibility of the bacteria to the antibiotic, which proved that the empirical treatment was adequate in most patients.
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The drug resistance of 82 strains of *Klebsiella pneumoniae.*
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4. Discussion
=============

Bacterial liver abscess is a disease that is potentially life-threatening. Since the liver has double blood supplies, that is, the hepatic artery and the portal vein, the portal vein, and the gastrointestinal tract are connected, leading to increased chance of pathogenic invasion of the liver and the subsequent inflammation of the liver parenchyma as well as necrosis of the hepatic tissue. With the use of antibiotics and immunosuppressants, the aging of the population, as well as the increasing kinds and the frequent use of medical equipment, the incidence of bacterial liver abscess continues to increase.^\[[@R12]\]^ This retrospective study suggests that compared with other patients, patients with diabetes mellitus may be more prone to get bacterial liver abscess, as the proportion of these patients differed significantly from the patients without diabetes mellitus. In addition, we found that *K pneumoniae* was the main pathogen that caused the bacterial liver abscess, compared with *E. coli*. The result was similar to previous studies.^\[[@R4],[@R12]\]^ The major manifestations of patients with bacterial liver abscess included fever, chills and pain caused by the abscess. In addition, one case of metastatic infection to the lung was found in this study. It has been reported that the invasion by the highly pathogenic *K pneumoniae* could lead to poor outcomes, such as endophthalmitis, meningitis, and necrotizing fasciitis.^\[[@R13]--[@R15]\]^ In our research, 5 patients had poor outcomes due to septic shock or the accompanying liver cancer, while other patients had good outcomes and were cured after antibiotics treatment combined with percutaneous drainage or surgery, as shown by the indicators that became normal after treatment, such as normal body temperature, reduced area of abscess, normal levels of WBC and C-reactive protein. Ultrasound-guided percutaneous portal vein catheterization is a simple and effective treatment for bacterial liver abscess with minimal invasiveness.^\[[@R16]\]^ With the use of ultrasound-guided puncture technique in the treatment of liver abscess, very few patients need surgical resection of the hepatic abscesses. This study found that the *K pneumoniae* that caused the bacterial liver abscess was less resistant to antibiotics than *E coli*. However, in a case reported in China, the enterobacteriaceae that caused the bacterial liver abscess was resistant to carbapenems and was also capable of producing ESBLs.^\[[@R17],[@R18]\]^ Clinically, immediately after collecting the specimens from the patients, we should properly preserve them, and isolate the pathogenic bacteria and carry out drug sensitivity tests as soon as possible, in order to obtain the best drug sensitivity result and thus provide correct guidance for choosing the appropriate antibiotics. In the present study, the empirical treatment was proved to be adequate to most patients, which was due to the correct decision of the physicians and the accurate etiological identification and susceptibility results. But there are still some limitations in our study. First, in this retrospective study, we failed to carry out further molecular analysis of the pathogens. Second, we did not explore the virulence of the *K pneumoniae*, as well as the relationship between the pathogens and the clinical manifestations.
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